Recommendations for advancing development of acute stroke therapies - Stroke Therapy Academic Industry Roundtable 3

被引:141
作者
Fisher, M [1 ]
机构
[1] Univ Massachusetts, Mem Healthcare, Dept Neurol, Worcester, MA 01605 USA
关键词
clinical trials; drug therapy; combination; patient selection; stroke management;
D O I
10.1161/01.STR.0000072983.64326.53
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background-The development of acute stroke therapy has proven to be a daunting task, with a few successful and many unsuccessful trials. New strategies need to be considered to enhance the chances for success in future trials. Summary of Review-The third Stroke Therapy Academic Industry Roundtable (STAIR) conference focused on issues related to increasing the percentage of acute stroke patients who might be included in acute stroke therapy trials and ultimately treated with drugs proven to be effective. A second focus was directed at the need for implementing multimodality stroke trials and potential ways to organize such trials in the near future. Finally, concepts for organizing and implementing acute stroke trials that incorporate current, state of the art trial methodology were discussed. Conclusions-It is hoped that these suggestions will enhance future stroke trials and the development of effective, new acute stroke treatments that are maximally effective and utilized.
引用
收藏
页码:1539 / 1546
页数:8
相关论文
共 83 条
[1]  
Adams HP, 2000, STROKE, V31, P601
[2]   Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II) [J].
Albers, GW ;
Bogousslavsky, J ;
Bozik, MA ;
Brass, LM ;
Broderick, JP ;
Fisher, M ;
Goldstein, LB ;
Salazar-Grueso, E ;
Akitsuki, S ;
Aranko, K ;
Ashwood, T ;
Atkinson, RP ;
Bell, RD ;
Brott, TG ;
Cady, WJ ;
Caplan, LR ;
Coggins, S ;
Cramer, S ;
Cyrus, P ;
Dayno, J ;
Easton, JD ;
Elliott, PJ ;
Finklestein, SP ;
Furlan, AJ ;
Gamzu, E ;
Glasky, MS ;
Gordon, K ;
Gorelick, PB ;
Greenwood, DT ;
Grotta, JC ;
Gunn, K ;
Hachinski, V ;
Hacke, W ;
Hall, ED ;
Hsu, CY ;
Humphreys, DM ;
Ishikawa, H ;
Jacobs, AJ ;
Kaste, M ;
Koroshetz, WJ ;
Krams, M ;
Lauritano, AA ;
Leclerc, J ;
Lees, KR ;
Lesko, L ;
Levine, SR ;
Levy, DE ;
Li, FH ;
Lyden, PD ;
Masayasu, H .
STROKE, 2001, 32 (07) :1598-1606
[3]   EFFECTS OF PUBLIC AND PROFESSIONAL-EDUCATION ON REDUCING THE DELAY IN PRESENTATION AND REFERRAL OF STROKE PATIENTS [J].
ALBERTS, MJ ;
PERRY, A ;
DAWSON, DV ;
BERTELS, C .
STROKE, 1992, 23 (03) :352-356
[4]   Metal ion chelation in neurodegenerative disorders [J].
Angel, I ;
Bar, A ;
Horovitz, T ;
Taler, G ;
Krakovsky, M ;
Resnitsky, D ;
Rosenberg, G ;
Striem, S ;
Friedman, JE ;
Kozak, A .
DRUG DEVELOPMENT RESEARCH, 2002, 56 (03) :300-309
[5]   Magnetic resonance imaging of acute stroke [J].
Baird, AE ;
Warach, S .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (06) :583-609
[6]   Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging [J].
Baird, AE ;
Benfield, A ;
Schlaug, G ;
Siewert, B ;
Lovblad, KO ;
Edelman, RR ;
Warach, S .
ANNALS OF NEUROLOGY, 1997, 41 (05) :581-589
[7]   HU-211, A NOVEL NONCOMPETITIVE N-METHYL-D-ASPARTATE ANTAGONIST, IMPROVES NEUROLOGICAL DEFICIT AND REDUCES INFARCT VOLUME AFTER REVERSIBLE FOCAL CEREBRAL-ISCHEMIA IN THE RAT [J].
BELAYEV, L ;
BUSTO, R ;
ZHAO, WZ ;
GINSBERG, MD .
STROKE, 1995, 26 (12) :2313-2319
[8]  
Bogousslavsky J, 1998, CEREBROVASC DIS, V8, P59
[9]   A systems approach to immediate evaluation and management of hyperacute stroke - Experience at eight centers and implications for community practice and patient care [J].
Brott, T ;
Broderick, J ;
Kothari, R ;
ODonoghue, M ;
Barsan, W ;
Tomsick, T ;
Spilker, J ;
Miller, R ;
Sauerbeck, L ;
Farrell, J ;
Kelly, J ;
Perkins, T ;
McDonald, T ;
Rorick, M ;
Hickey, C ;
Armitage, J ;
Perry, C ;
Thalinger, K ;
Rhude, R ;
Schill, J ;
Becker, PS ;
Heath, RS ;
Adams, D ;
Reed, R ;
Klei, M ;
Hughes, A ;
Anthony, J ;
Baudendistel, D ;
Zadicoff, C ;
Rymer, M ;
Bettinger, I ;
Laubinger, P ;
Schmerler, M ;
Meiros, G ;
Lyden, P ;
Dunford, J ;
Zivin, J ;
Rapp, K ;
Babcock, T ;
Daum, P ;
Persona, D ;
Brody, M ;
Jackson, C ;
Lewis, S ;
Liss, J ;
Mahdavi, Z ;
Rothrock, J ;
Tom, T ;
Zweifler, R ;
Kobayashi, J .
STROKE, 1997, 28 (08) :1530-1540
[10]   Comparison of TNK with wild-type tissue plasminogen activator in a rabbit embolic stroke model [J].
Chapman, DF ;
Lyden, P ;
Lapchak, PA ;
Nunez, S ;
Thibodeaux, H ;
Zivin, J .
STROKE, 2001, 32 (03) :748-752